日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Noncanonical EZH2 activity cooperates with FOXM1 to drive tumorigenesis and advanced progression in HCC

非经典 EZH2 活性与 FOXM1 协同作用,驱动肝细胞癌的肿瘤发生和进展。

Jung, Sungju; Bang, Hyun Jin; Park, Myong-Suk; Lee, Kyung Hwa; Hennighausen, Lothar; Yoo, Kyung Hyun; Bae, Woo Kyun

LGALS3BP Induces Insulin Resistance via TLR2-IKKα/β Pathway-Mediated IRS1 Serine Phosphorylation.

LGALS3BP 通过 TLR2-IKKα/β 通路介导的 IRS1 丝氨酸磷酸化诱导胰岛素抵抗。

Sung Minjeong, Kim Dae-Hwan, Sun Eun-Gene, Hwang Jun-Eul, Cho Sang-Hee, Chung Ik-Joo, Shim Hyun-Jeong, Bae Woo Kyun

Long-term Immunogenicity of the 13-valent Pneumococcal Conjugate Vaccine during Adjuvant Chemotherapy in Patients with Gastric and Colorectal Cancer: A 5-Year Follow-up of a Randomized Controlled Trial

13价肺炎球菌结合疫苗在胃癌和结直肠癌患者辅助化疗期间的长期免疫原性:一项随机对照试验的5年随访

Kim, Hyeon-Jong; Bang, Hyunjin; Shim, Hyun-Jung; Hwang, Jun Eul; Cho, Sang-Hee; Chung, Ik-Joo; Kang, Seung Ji; Kim, Jong Gwang; Beom, Seung-Hoon; Jang, A-Yeung; Song, Joon Young; Bae, Woo Kyun

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma

EV-302/KEYNOTE-A39 泛亚洲亚组分析:一项评估恩福妥单抗和帕博利珠单抗治疗未经治疗的晚期尿路上皮癌患者的 3 期研究

Kikuchi, Eiji; Van der Heijden, Michiel S; Valderrama, Begoña P; Gupta, Shilpa; Bedke, Jens; Shin, Sang Joon; Li, Jian-Ri; Guo, Jun; Danchaivijitr, Pongwut; Kanesvaran, Ravindran; Park, Se Hoon; Su, Wen-Pin; Kandori, Shuya; Bae, Woo Kyun; Wong, Alvin; Gorla, Seema; Bavle, Abhishek; Yu, Xuesong; Lu, Yi-Tsung; Powles, Thomas

The Impact of 5-HTTLPR Polymorphism on Depression and Lymphocyte Changes in Colorectal Cancer Patients Undergoing FOLFOX Chemotherapy

5-HTTLPR多态性对接受FOLFOX化疗的结直肠癌患者抑郁症和淋巴细胞变化的影响

Kim, Seon-Young; Jhon, Min; Kim, Sung-Wan; Ryu, Seunghyong; Shin, Il-Seon; Kang, Hee-Ju; Lee, Ju-Yeon; Shim, Hyun-Jeong; Hwang, Jun Eul; Bae, Woo Kyun; Choi, Hyun-Woo; Shin, Myung Geun; Kim, Jae-Min

Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti-PD-1 therapy

循环免疫细胞中STAT3的体外磷酸化:一种用于早期癌症诊断和抗PD-1疗法反应的新型生物标志物

Lee, Sung-Woo; Kim, Young Ju; Jeong, Saei; Rho, Kyung Na; Noh, Jeong Eun; Kim, Hee-Ok; Cho, Hyun-Ju; Choi, Yoo Duk; Yang, Deok Hwan; Hwang, Eu Chang; Bae, Woo Kyun; Yun, Sook Jung; Yun, Ju Sik; Park, Cheol-Kyu; Oh, In-Jae; Cho, Jae-Ho

FGFR4 promotes CAF activation through the CXCL10-CXCR3 axis in colon cancer.

FGFR4 通过 CXCL10-CXCR3 轴促进结肠癌中的 CAF 活化

Sun Eun-Gene, Choi Ji-Na, Park Mi-Ra, Kim Dae-Hwan, Sung MinJeong, Shim Hyun-Jeong, Hwang Jun-Eul, Bae Woo-Kyun, Jung Chaeyong, Kim Young-Kook, Chung Ik-Joo, Cho Sang-Hee

Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer

扩增自然杀伤细胞与阿特珠单抗联合疗法在小细胞肺癌中发挥强大的抗肿瘤免疫作用

Vo, Manh-Cuong; Nguyen, Van-Tan; Tran, Van-Dinh-Huan; Oh, Hyung-Joo; Jung, Sung-Hoon; Bae, Woo Kyun; Lee, Je-Jung; Oh, In-Jae

Synergistic Anti-Tumor Efficacy of Modified FOLFIRINOX and NK Cell Therapy in Pancreatic Ductal Adenocarcinoma.

改良FOLFIRINOX方案与NK细胞疗法在胰腺导管腺癌中的协同抗肿瘤疗效

Park Hye-Seong, Hwang Jun Eul, Lee Je-Jung, Bae Woo Kyun

A Prospective, Single-Cohort, Open, Multi-center, Observational Study of Sublingual Fentanyl for Breakthrough Cancer Pain: Effectiveness, Safety, and Tolerability in Korean Cancer Patients

一项前瞻性、单队列、开放标签、多中心、观察性研究,旨在评估舌下芬太尼治疗突破性癌痛在韩国癌症患者中的有效性、安全性和耐受性。

Choi, Youn Seon; Koh, Su-Jin; Bae, Woo Kyun; Kim, Se Hyung; Shin, Seong Hoon; Oh, So Yeon; Bae, Sang Byung; Yang, Yaewon; Song, Eun-Kee; Cho, Yoon Young; Lee, Pyung Bok; Oh, Ho-Suk; Lee, MinYoung; Ahn, Jin Seok